Literature DB >> 24995103

Autosplenectomy in severity of sickle cell diseases.

Mehmet Rami Helvaci1, Can Acipayam1, Ramazan Davran1.   

Abstract

BACKGROUND: We tried to understand whether or not there is an association between prevalence of autosplenectomy and severity of sickle cell diseases (SCDs).
METHODS: All SCDs patients with red blood cell (RBC) transfusions of less than 50 units in their lives were put into the first group and 50 units or higher were put into the second group.
RESULTS: The study included 316 patients (155 females). There were 224 cases (70.8%) in the first group and 92 cases (29.1%) in the second group (p<0.001). The male ratio was significantly higher in the second group (64.1% versus 45.5%, p<0.001). Although both the white blood cell and platelet counts were higher in the second group, there was a significant difference in platelet counts (p=0.005), and this was probably due to the small sample sizes. Although the prevalence of autosplenectomy was significantly higher in the first group (56.2% versus 45.6%, p<0.05), the mean number of painful crises per year, digital clubbing, chronic obstructive pulmonary disease (COPD), leg ulcers, stroke, chronic renal disease (CRD) and coronary heart disease (CHD) were significantly higher in the second groups (p<0.05 for all).
CONCLUSION: In contrast to the lower prevalence of autosplenectomy, the mean number of painful crises per year, digital clubbing, COPD, leg ulcers, stroke, CRD, and CHD were significantly higher in the second group. So there may be an inverse relationship between prevalence of autosplenectomy and severity of SCDs, and spleen may act as a chronic inflammatory focus as a filter of blood for these abnormally hard RBCs.

Entities:  

Keywords:  Autosplenectomy; chronic capillary damage; sickle cell diseases

Year:  2014        PMID: 24995103      PMCID: PMC4073764     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  24 in total

1.  Prediction of adverse outcomes in children with sickle cell disease.

Authors:  S T Miller; L A Sleeper; C H Pegelow; L E Enos; W C Wang; S J Weiner; D L Wethers; J Smith; T R Kinney
Journal:  N Engl J Med       Date:  2000-01-13       Impact factor: 91.245

2.  Personal experience.

Authors:  L Schamroth
Journal:  S Afr Med J       Date:  1976-02-28

Review 3.  Mechanism of action of hydroxyurea in the management of sickle cell anemia in adults.

Authors:  S Charache
Journal:  Semin Hematol       Date:  1997-07       Impact factor: 3.851

4.  Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension.

Authors:  Micah R Fisher; Paul R Forfia; Elzbieta Chamera; Traci Housten-Harris; Hunter C Champion; Reda E Girgis; Mary C Corretti; Paul M Hassoun
Journal:  Am J Respir Crit Care Med       Date:  2009-01-22       Impact factor: 21.405

Review 5.  The metabolic syndrome.

Authors:  Robert H Eckel; Scott M Grundy; Paul Z Zimmet
Journal:  Lancet       Date:  2005 Apr 16-22       Impact factor: 79.321

6.  Is pain crisis a cause of death in sickle cell disease?

Authors:  N A Parfrey; W Moore; G M Hutchins
Journal:  Am J Clin Pathol       Date:  1985-08       Impact factor: 2.493

7.  Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia.

Authors:  S Charache; F B Barton; R D Moore; M L Terrin; M H Steinberg; G J Dover; S K Ballas; R P McMahon; O Castro; E P Orringer
Journal:  Medicine (Baltimore)       Date:  1996-11       Impact factor: 1.889

8.  Metformin and parameters of physical health.

Authors:  Mehmet Rami Helvaci; Hasan Kaya; Ali Borazan; Cahit Ozer; Mahmut Seyhanli; Atilla Yalcin
Journal:  Intern Med       Date:  2008-04-16       Impact factor: 1.271

9.  Identification of splenic reservoir monocytes and their deployment to inflammatory sites.

Authors:  Filip K Swirski; Matthias Nahrendorf; Martin Etzrodt; Moritz Wildgruber; Virna Cortez-Retamozo; Peter Panizzi; Jose-Luiz Figueiredo; Rainer H Kohler; Aleksey Chudnovskiy; Peter Waterman; Elena Aikawa; Thorsten R Mempel; Peter Libby; Ralph Weissleder; Mikael J Pittet
Journal:  Science       Date:  2009-07-31       Impact factor: 47.728

10.  Prevalence, aetiologies and significance of clubbing in a department of general internal medicine.

Authors:  X Vandemergel; B Renneboog
Journal:  Eur J Intern Med       Date:  2008-02-11       Impact factor: 4.487

View more
  5 in total

1.  Mortal quintet of sickle cell diseases.

Authors:  Mehmet Rami Helvaci; Cumali Gokce; Ramazan Davran; Seckin Akkucuk; Mustafa Ugur; Cem Oruc
Journal:  Int J Clin Exp Med       Date:  2015-07-15

2.  Tonsilectomy in sickle cell diseases.

Authors:  Mehmet Rami Helvaci; Cumali Gokce; Ramazan Davran; Can Acipayam; Seckin Akkucuk; Mustafa Ugur
Journal:  Int J Clin Exp Med       Date:  2015-03-15

3.  Acute chest syndrome in severity of sickle cell diseases.

Authors:  Mehmet Rami Helvaci; Can Acipayam; Akin Aydogan; Seckin Akkucuk; Cem Oruc; Cumali Gokce
Journal:  Int J Clin Exp Med       Date:  2014-12-15

4.  Mantle Cell Hyperplasia of Peripheral Lymph Nodes as Initial Manifestation of Sickle Cell Disease.

Authors:  Ahmad Monabbati; Sadat Noori; Akbar Safaei; Mani Ramzi; Seyedsajjad Eghbali; Ali Adib
Journal:  Case Rep Hematol       Date:  2016-10-30

5.  HAEMATOLOGICAL PROFILE AND BLOOD TRANSFUSION PATTERN OF PATIENTS WITH SICKLE CELL ANAEMIA VARY WITH SPLEEN SIZE.

Authors:  F A Fasola; A J Adekanmi
Journal:  Ann Ib Postgrad Med       Date:  2019-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.